AUTOANTIBODY IN JUVENILE DERMATOMYOSITIS REFLECTS DISEASE ACTIVITY: RESULTS OF A PILOT STUDY

被引：0
|
作者：
Tansley, Sarah L. [1 ]
Gunawardena, Harsha [2 ]
Betteridge, Zoe E. [3 ]
Arnold, Katie [4 ]
Shaddick, Gavin [5 ]
Wedderburn, Lucy R. [4 ]
McHugh, Neil J. [1 ]
机构：
[1] RNHRD, Dept Rheumatol, Bath, Avon, England
[2] North Bristol NHS Trust, Dept Rheumatol, Bristol, Avon, England
[3] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England
[4] UCL, Inst Child Hlth, Dept Rheumatol, London, England
[5] Univ Bath, Dept Math, Bath BA2 7AY, Avon, England
来源：
RHEUMATOLOGY | 2014年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O57
引用
收藏
页码：54 / 55
页数：2
相关论文
共 50 条
  • [31] Disease activity score for children with juvenile dermatomyositis: Reliability and validity evidence
    Bode, RK
    Klein-Gitelman, MS
    Miller, ML
    Lechman, TS
    Pachman, LM
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2003, 49 (01): : 7 - 15
  • [32] Juvenile dermatomyositis presenting with anasarca: A possible indicator of severe disease activity
    Mitchell, JP
    Dennis, GJ
    Rider, LG
    JOURNAL OF PEDIATRICS, 2001, 138 (06): : 942 - 945
  • [33] Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy
    Curiel, Rodolfo
    Nguyen, William
    Mamyrova, Gulnara
    Jones, Derek
    Ehrlich, Alison A.
    Brindle, Kathleen
    Haji-Momenian, Shahriar
    Sheets, Robert
    Kim, Hanna Y.
    Jones, Olcay G.
    Rider, Lisa
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 (07) : 1229 - 1237
  • [34] HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositisscleroderma overlap
    Wedderburn, L. R.
    McHugh, N. J.
    Chinoy, H.
    Cooper, R. G.
    Salway, F.
    Ollier, W. E. R.
    McCann, L. J.
    Varsani, H.
    Dunphy, J.
    North, J.
    Davidson, J. E.
    RHEUMATOLOGY, 2007, 46 (12) : 1786 - 1791
  • [35] Association of type I interferon subtypes and disease activity in juvenile dermatomyositis
    Moreau, T.
    Bondet, V.
    Ramos, J.
    Ouldali, N.
    Albert-Vega, C.
    Bodemer, C.
    Eveillard, L.
    Fournier, B.
    Fremond, M.
    Gitiaux, C.
    Herbeuval, J.
    Isapof, A.
    Quartier, P.
    Rahal, F.
    Vinit, C.
    Welfringer, A.
    Melki, I.
    Bader-Meunier, B.
    Duffy, D.
    Rodero, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 402 - 402
  • [36] Looking for BlyS(BAFF) in Juvenile Dermatomyositis: A New Biomarker of Disease Activity
    Costin, Christopher
    Morgan, Gabrielle
    Khojah, Amer
    Pachman, Lauren
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3694 - 3695
  • [37] Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset
    Tansley, Sarah L.
    Betteridge, Zoe E.
    Shaddick, Gavin
    Gunawardena, Harsha
    Arnold, Katie
    Wedderburn, Lucy R.
    McHugh, Neil J.
    RHEUMATOLOGY, 2014, 53 (12) : 2204 - 2208
  • [38] Juvenile Dermatomyositis: A Case Study
    Schneider, Michelle
    Murphy, Kathleen
    JOURNAL OF PEDIATRIC HEALTH CARE, 2011, 25 (01) : 38 - 43
  • [39] Longitudinal Disease Trajectory of Juvenile Dermatomyositis
    Lim, Lily Siok Hoon
    Pullenayegum, Eleanor
    Gladman, D. D.
    Silverman, Earl D.
    Feldman, Brian M.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S41 - S41
  • [40] JUVENILE DERMATOMYOSITIS - PATHOPHYSIOLOGY AND DISEASE EXPRESSION
    PACHMAN, LM
    PEDIATRIC CLINICS OF NORTH AMERICA, 1995, 42 (05) : 1071 - &
12345